pta20241206018
Business news for the stock market

QLUPOD AG: QluPod announces launch in retail Switzerland

Main

Herisau (pta018/06.12.2024/12:00 UTC+1)

A significant milestone: Qlupod soon available in the best-known Swiss retail

shops

The year 2024 is shaping up to be a very successful year for Qlupod AG and the

company is experiencing a period of growth and innovation. Therefore, after extensive

discussions and negotiations and the tireless work of the entire team, we are pleased

to announce the cooperation with Secomp AG. Secomp AG is one of the leading

companies in Europe for supplying retailers in Germany, France, Switzerland and the

Netherlands. Consumers in Switzerland are expected to be able to purchase the

QluPod health monitor in the country's best-known retail shops and some of the

largest Swiss online shops from mid-January.

A medical device for everyday life: vital data always in view

With the availability of the QluPod in retail stores and leading online shops in

Switzerland, Qlupod AG has achieved one of its ambitious goals. In future, the health

monitor will have a decisive impact on consumers' everyday lives and medical care.

The reliable device is so compact and handy that it even fits in a trouser pocket. At

the same time, the QluPod is CE-certified and tested by TÜV. This means that buyers

are not getting a lifestyle gadget, but a fully-fledged medical device that can also be

used by doctors and care services.

Use the QluPod to measure and monitor the five most important vital signs: heart

rate, blood oxygen saturation, body temperature, ECG and blood pressure. You can

save the values in the QluPod app and share them in real time with your doctor, carer

or relatives. The high quality and approval as a medical device are decisive aspects

that speak in favour of the safety and reliability of the health monitor and clearly set

the device apart from similar products on the market. With the QluPod, users can

monitor their health independently and autonomously and utilise the numerous

benefits of telemedicine from home.

Growth opportunities and future prospects

The launch of the QluPod in the Swiss retail sector and the cooperation with a strong

distribution partner on the international retail market represent a milestone in the

young history of the start-up from Herisau. "We are on a promising path to a

successful market launch," explains Nikola Trajanov, Interim CEO of Qlupod AG. "Our

current developments and market analyses show that we have great potential to take

a significant position in telemedicine. However, we are faced with the challenge that

we lack the necessary liquidity to achieve our growth targets and make the necessary

investments in the further development of the QluPod and the associated apps. We

are therefore dependent on additional investors in order to realise our visions and putour company on a solid financial footing in the long term. For these reasons, we are

continuing to look for financially strong partners with international growth ambitions in

order to consistently implement our strategy and achieve the goals we have set

ourselves."

About Qlupod:

Qlupod AG is a start-up company in the field of telemedicine and develops innovative

solutions to make patient care efficient and cost-effective. With the QluPod device and

the associated software, the company is endeavouring to shape the future of healthcare.

The offering is aimed at hospitals, care facilities, medical professionals and private

individuals who want to monitor their health independently.

For more information about Qlupod AG and our products, please visit our website at

www.qlupod.com.

Disclaimer:

This publication constitutes neither an offer to sell nor a solicitation to buy securities.

Insofar as this document contains forward-looking statements, these do not represent

facts and are characterised by the words "expect", "believe", "estimate", "intend",

"aim", "assume" and similar expressions. These statements express the intentions,

opinions or current expectations and assumptions of Qlupod AG and are based on

current plans, estimates and forecasts which Qlupod AG has made to the best of its

knowledge, but do not claim to be correct in the future. Forward-looking statements are

subject to risks and uncertainties that are difficult to predict and are usually beyond the

control of Qlupod AG. It should be noted that actual events or developments may differ

materially from the events and developments expressed or implied by such forward-

looking statements.

(end)

Emitter: QLUPOD AG
Bahnhofstrasse 23
9100 Herisau
Switzerland
Contact Person: Nikola Trajanov
Phone: +41 71 510 05 45
E-Mail: ir@qlupod.com
Website: qlupod.eu
ISIN(s): CH1222316429 (Share)
Stock Exchange(s): -
Other Stock Exchanges: Regelmaessige Kursfeststellung Schweiz
|